Tennessee § 56-13-203 Required filings

Tennessee Statutes

§ 56-13-203 — Required filings

Tennessee § 56-13-203

Title56

This text of Tennessee § 56-13-203 (Required filings) is published on Counsel Stack Legal Research, covering Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tenn. Code Ann. § 56-13-203 (2026).

Text

In addition to the information required by § 56-13-103(c)(1) , each applicant-protected cell captive insurance company shall file with the commissioner the following:

(1)Materials demonstrating how the applicant will account for the loss and expense experience of each protected cell at a level of detail found to be sufficient by the commissioner, and how it will report such experience to the commissioner;

(2)A statement acknowledging that all financial records of the applicant, including records pertaining to any protected cells, shall be made available for inspection or examination by the commissioner or the commissioner's designated agent;

(3)All contracts or sample contracts between the applicant and any participants; and (4) Evidence that expenses shall be allocated to each protecte

Free access — add to your briefcase to read the full text and ask questions with AI

In addition to the information required by § 56-13-103(c)(1) , each applicant-protected cell captive insurance company shall file with the commissioner the following: (1) Materials demonstrating how the applicant will account for the loss and expense experience of each protected cell at a level of detail found to be sufficient by the commissioner, and how it will report such experience to the commissioner; (2) A statement acknowledging that all financial records of the applicant, including records pertaining to any protected cells, shall be made available for inspection or examination by the commissioner or the commissioner's designated agent; (3) All contracts or sample contracts between the applicant and any participants; and (4) Evidence that expenses shall be allocated to each protected cell in a fair and equitable manner.